Frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)
2006

Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17

publication Evidence: moderate

Author Information

Author(s): Wszolek Zbigniew K, Tsuboi Yoshio, Ghetti Bernardino, Pickering-Brown Stuart, Baba Yasuhiko, Cheshire William P

Hypothesis

What are the genetic and clinical characteristics of frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17)?

Conclusion

FTDP-17 is a rare neurodegenerative disorder caused by mutations in the tau gene, leading to variable clinical presentations and a generally poor prognosis.

Supporting Evidence

  • FTDP-17 is caused by mutations in the tau gene, which is important for neuron function.
  • The disease can lead to behavioral changes, cognitive decline, and motor symptoms.
  • Diagnosis requires a combination of clinical features and genetic analysis.

Takeaway

FTDP-17 is a rare brain disease that affects how people think and move, caused by changes in a specific gene. It can make people act differently and have trouble with their movements.

Methodology

The study involved a review of clinical features, genetic mutations, and diagnostic criteria for FTDP-17.

Limitations

The prevalence and incidence of FTDP-17 are unknown, and the clinical information available for some families is not detailed enough.

Participant Demographics

Affected individuals are from various countries, with a familial history of the disorder.

Digital Object Identifier (DOI)

10.1186/1750-1172-1-30

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication